Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · STAAR Surgical (STAA)

STAAR Surgical's Chief Legal Officer Nathaniel Sisitsky departs effective February 4, 2026

Neutral Impact 3 of 5 leadership Written later

STAAR Surgical ended the employment of Chief Legal Officer and Corporate Secretary Nathaniel Sisitsky effective February 4, 2026, treating it as a termination without cause. He will serve as a consultant through March 13, 2026 to help transition the legal function, and his severance and equity terms were set under a 2023 severance agreement and a new letter agreement.

Key points

  • Separation effective February 4, 2026; treated as a termination by the Company without cause
  • Severance equal to 12 months of base salary plus 12 months of insurance premium reimbursement, subject to a general release
  • Consulting fees of $8,000 per week through March 13, 2026, plus a $10,000 Completion Fee if the services are completed
  • Other unvested equity awards forfeited for no consideration; March 2026 RSUs accelerated and vested

The filing

CompanySTAAR Surgical (STAA)
Form8-K, current report
Filed with the SECFeb 5, 2026, 8:06 AM ET
Accession number0001193125-26-038534

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 05, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.